Multiple Sclerosis: NHS to offer take-at-home tablet
Thousands of NHS patients in England with multiple sclerosis (MS) will soon be offered a "take at home" tablet to manage their condition, sparing them hospital visits for injections or infusions. Cladribine can help people with the active relapsing-remitting version of the disease, as well as more severe, highly active MS, for which it is already used, says drug advisory body NICE. Broadening access to the drug should give more patients freedom from hospital and free up clinic time, say experts. The NHS is the first healthcare system in Europe to roll out the treatment.
NICE is expected to issue final guidance for England in April, with access in Wales and Northern Ireland likely to follow. Scotland is also considering it.There are more than 150,000 people living with MS - a condition that affects the brain and spinal cord - in the UK. Although it cannot currently be cured, treatment can slow the disease and ease symptoms.Trials show cladribine can reduce the number and severity of relapses. The drug targets certain immune cells involved in inflammation and myelin damage in MS.It is given in two treatment courses, 12 months apart, which would mean patients would take about 20 tablets at home. The list price is around £2,000 per tablet, but it is not clear how much the NHS is paying since it can negotiate discounts with drug companies. It is estimated about 2,000 patients could be offered the treatment over the first three years.
Clare Elgar, 37, from Southampton, has taken cladribine for her relapsing MS, which was diagnosed in January 2021 after experiencing loss of function in her right arm and numbness across her face. Clare says: "Being able to take the treatment at home meant I could maintain my day-to-day routine and not have to travel to hospital. I'm thrilled that the new criteria will now give others like me the opportunity to benefit from this life-changing medication."Laura Thomas, head of policy at the MS Society, said: "This decision could particularly benefit people who'd struggle to go into hospital regularly, like younger working-age adults."It will also benefit patients considering starting a family, as it's safe to get pregnant six months after the final course of treatment - which is less restrictive than many other options - according to Ms Thomas. "We're so glad that more people with MS will now be able to choose an effective treatment which suits their lifestyle."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
38 minutes ago
- The Independent
Britain morphing into ‘National Health State', says think tank
Britain is turning into a 'National Health State', a think tank has said after the Chancellor gave the NHS a major funding boost in her spending review. The health service was the big winner of Wednesday's spending review, receiving an extra £29 billion per year for day-to-day spending and more cash for capital investment. Overnight, the Resolution Foundation said Rachel Reeves's announcements had followed a recent trend that saw increases for the NHS come at the expense of other public services. Ruth Curtice, chief executive of the Resolution Foundation, said: 'Health accounted for 90% of the extra public service spending, continuing a trend that is seeing the British state morph into a National Health State, with half of public service spending set to be on health by the end of the decade.' Defence was another of Wednesday's winners, Ms Curtice said, receiving a significant increase in capital spending while other departments saw an overall £3.6 billion real-terms cut in investment. The Institute for Fiscal Studies (IFS) made similar arguments about 'substantial' investment in the NHS and defence coming at the expense of other departments, although the think tank's director Paul Johnson warned the money may not be enough. He said: 'Aiming to get back to meeting the NHS 18-week target for hospital waiting times within this Parliament is enormously ambitious – an NHS funding settlement below the long-run average might not measure up. 'And on defence, it's entirely possible that an increase in the Nato spending target will mean that maintaining defence spending at 2.6% of GDP no longer cuts the mustard.' Ms Curtice added that low and middle-income families had also done well out of the spending review 'after two rounds of painful tax rises and welfare cuts', with the poorest fifth of families benefiting from an average of £1,700 in extra spending on schools, hospitals and the police. She warned that, without economic growth, another round of tax rises was likely to come in the autumn as the Chancellor seeks to balance the books. She said: 'The extra money in this spending review has already been accounted for in the last forecast. 'But a weaker economic outlook and the unfunded changes to winter fuel payments mean the Chancellor will likely need to look again at tax rises in the autumn.' Speaking after delivering her spending review, Ms Reeves insisted she would not have to raise taxes to cover her spending review. She told GB News: 'Every penny of this is funded through the tax increases and the changes to the fiscal rules that we set out last autumn.'
The Independent
an hour ago
- The Independent
The NHS will receive £6bn in funding. Here's how it will be used
Rachel Reeves has pledged a £6bn investment to accelerate NHS tests and treatments, following substantial budget increases. The funding aims to provide new scanners, ambulances, and urgent treatment centres, delivering up to four million more tests and procedures in five years. This investment supports the government's goal of reducing NHS waiting lists in England, with Labour aiming for 92 per cent of routine operations to be carried out within 18 weeks. Health Secretary Wes Streeting said the investment will generate millions more diagnostic tests, scans, and procedures, building on 3.6 million extra elective care appointments already delivered. Health leaders are sceptical, with Matthew Taylor of the NHS Confederation warning that the £29bn increase may not cover rising costs and guarantee waiting time targets, while Sarah Woolnough of the King's Fund questions how all NHS needs can be met with this settlement alone.
Powys County Times
an hour ago
- Powys County Times
MS calls for clarity after livestock ban at Royal Welsh Show
Livestock entries have been banned from certain areas at this year's Royal Welsh Show and an MS is calling for clarity. The decision follows the introduction restrictions due to the spread of the bluetongue virus, which could result in around 40 per cent fewer cattle taking part in the event. James Evans MS raised the issue in the Senedd and called on the Welsh Government to issue a clear statement on its approach to the outbreak. Mr Evans said: "We need clarity from Welsh Government as to their approach on tackling Bluetongue. "We should be following the lead of England on this. "Many farmers in my constituency are cross-border, accessing markets in Hereford, and we need to ensure that farmers are not punished. "I hope that the much-needed clarity will come before the Royal Welsh Show and that this decision may be reconsidered. "This is not the first time the show has been beset with restrictions due to disease, and I am sure the show will go on."
